1524 related articles for article (PubMed ID: 16053011)
1. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
2. Anemia management and treatment response in patients on hemodialysis: the MAR study.
Portolés J; López-Gómez JM; Aljama P
J Nephrol; 2006; 19(3):352-60. PubMed ID: 16874697
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
Portolés J; López-Gómez JM; Aljama P
Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
[TBL] [Abstract][Full Text] [Related]
7. [Predictors of early death during dialysis].
Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of anemia in patients with chronic kidney disease.
McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
[TBL] [Abstract][Full Text] [Related]
9. [Occult chronic kidney disease (OCKD), and cardiovascular risk factors. Epidemiologic study].
Otero A; Abelleira A; Gayoso P
Nefrologia; 2005; 25(3):275-87. PubMed ID: 16053009
[TBL] [Abstract][Full Text] [Related]
10. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
11. The challenge of cardiovascular risk factors in end-stage renal disease.
Covic A; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2003; 16(4):476-86. PubMed ID: 14696749
[TBL] [Abstract][Full Text] [Related]
12. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?
Fleischmann EH; Bower JD; Salahudeen AK
Clin Nephrol; 2001 Sep; 56(3):221-30. PubMed ID: 11597037
[TBL] [Abstract][Full Text] [Related]
13. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease.
Portolés J; Castelao AM; Gorriz JL; Tato AM; de Alvaro F
Ren Fail; 2009; 31(10):869-75. PubMed ID: 20030520
[TBL] [Abstract][Full Text] [Related]
14. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study].
Poch E; Martinez X; Rodrigo JA; Tovar JL;
Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899
[TBL] [Abstract][Full Text] [Related]
15. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
[TBL] [Abstract][Full Text] [Related]
16. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
[TBL] [Abstract][Full Text] [Related]
18. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
[TBL] [Abstract][Full Text] [Related]
19. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
20. [Renal insufficiency is an important cardiovascular risk factor].
Pérez Flores I; Luño J
Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
